Maximize your Discovery Hit/Rate

Repurpose your drug candidate with our new Combination assay with radiotherapy



We developed an in vitro 3D-spheroid model to measure the efficacy of drug candidates with FDA-approved radiotherapy. Allowing our customers to get more from their pipeline.


From cell-lines or patient-derived cells, we tailor a 3D cell model for the combination of your drug candidates.